chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hodgkin lymphoma x 2 yrs" (unspecified if ongoing), notes: Hodgkin lymphoma x 2 yrs; "Asthma" (unspecified if ongoing); "known allergies:sulfa drugs" (unspecified if ongoing), notes: known allergies: sulfa drugs; "known allergies: milk products" (unspecified if ongoing), notes: known allergies: milk products. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 09Feb2023 to 13Feb2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
50 cents sized red raised area, hive like appearance non-itchy lt upper arm; ice applied, swelling reduced;
This spontaneous report as received from a reporter of unspecified profession refers to a patient of unknown demographics. On an unknown date the patient was vaccinated with M-M-R II. Dose, lot and expiry date were unknown. The patient received the first dose of M-M-R II at kindergarten age (unspecified age). No adverse effect was reported. Additional information has been requested.
Pt brought in due to lump post vaccine left thigh, no cystic lesion, no erythema, no warm to touch, firm, febrile, no tender. Vaccine given 05/30/02, pt in on 06/04/02. Has follow-up 06/05/02.
pt recv vax 7/96 & in 3/98 pt exp ``very severe'' chickenpox. treated w/Zovirax
dizziness; muscle pain; headache; fatigue; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 14Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced dizziness, muscle pain, headache and fatigue on an unspecified date in Jan2021. Outcome of the events was unknown.   No follow-up attempts are possible. Information about batch/ lot number cannot be obtained.
18 bumps on right forearm; This spontaneous case was reported by a consumer and describes the occurrence of RASH PAPULAR (18 bumps on right forearm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RASH PAPULAR (18 bumps on right forearm). At the time of the report, RASH PAPULAR (18 bumps on right forearm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-222973 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up contain non significant information
Moderna 2/9/21, 3/9/21. Positive on 2/10/2023
Patient has redness and swelling in the right and left deltoid injection sites. Denies further symptoms. Mother reports the swelling started today and got significantly worse in a short period of time.
Eruption on the right side of the face; Difficulty breathing at night - trouble breathing; standing up she feels dizzy; waking up at night because she has trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Eruption on the right side of the face), NOCTURNAL DYSPNOEA (Difficulty breathing at night - trouble breathing), DIZZINESS POSTURAL (standing up she feels dizzy) and SLEEP DISORDER (waking up at night because she has trouble breathing) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 025C21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for Vitamin supplementation.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced RASH (Eruption on the right side of the face), NOCTURNAL DYSPNOEA (Difficulty breathing at night - trouble breathing), DIZZINESS POSTURAL (standing up she feels dizzy) and SLEEP DISORDER (waking up at night because she has trouble breathing). At the time of the report, RASH (Eruption on the right side of the face), NOCTURNAL DYSPNOEA (Difficulty breathing at night - trouble breathing), DIZZINESS POSTURAL (standing up she feels dizzy) and SLEEP DISORDER (waking up at night because she has trouble breathing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: Increased.          Treatment information were not provided.
(L) arm pain, vomiting, malaise, R/O sepsis-doubtful. Pt with prior diagnosis of staph infections
Cough; Body aches; I am tired because I have been sleeping a lot; Injection site pain; Chills; I am tired because all I do I have been sleeping a lot; This is a spontaneous report from a contactable consumer (patient).  A 61-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0187) via an unspecified route of administration on 29May2021 in upper right arm as 1st dose single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 30May2021, the patient experienced cough, some body aches, she was tired, she got the pain at the injection site which she knew was common anyway, little bit of chills but nothing major. She was tired because all she did was sleeping a lot. She just wanted to know if she could take amphetamines (treatment), if it could help alleviate some of those side effects. She wanted to know if it was safe to do that or not. The outcome of all events was unknown.  Consumer was informed about Pfizer Medical Information Department.  Information on Lot/Batch number was available. Additional information has been requested.
Couldn't walk for a second and it went away, very brief; Sore arm; Cold sore, Canker sore on inside of lip; Low grade fever; Weird feeling; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip), FEELING ABNORMAL (Weird feeling) and PYREXIA (Low grade fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Herpes NOS (She sometimes gets herpes break outs).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING ABNORMAL (Weird feeling). On an unknown date, the patient experienced GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever). At the time of the report, GAIT DISTURBANCE (Couldn't walk for a second and it went away, very brief), PAIN IN EXTREMITY (Sore arm), LIP PAIN (Cold sore, Canker sore on inside of lip) and PYREXIA (Low grade fever) outcome was unknown and FEELING ABNORMAL (Weird feeling) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) low grade fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was also having MACFS as concomitant medication for chronic fatigue syndrome. Treatment information was not provided.
This spontaneous report as received from a pharmacist refers to a 71 year old female patient with lung infection and diltiazem (manufacturer unknown) allergy (MARRS #). The patient's medical history included Chronic Obstructive Pulmonary Disease (COPD). On 11-SEP-2013 the patient was vaccinated with ZOSTAVAX (lot # J002242, 21-MAY-2014) 0.65 ml, subcutaneous. Concomitant therapies included Levothyroxine sodium (manufacturer unknown), Levofloxacin, DEXILANT, Atenolol, Digoxin and SPIRIVA. Pharmacist stated that on 12-SEP-2013 patient visited physician for a "lung issue". Physician prescribed patient to receive Prednisone (manufacturer unknown0 for lung issue. Pharmacist stated patient had a history of COPD and had received a MEDROL dose pack for an unspecified lung infection the month prior to ZOSTAVAX administration, in approximately August 2013. Pharmacist stated "seems patient had been battling a lung infection for a few months". The outcome of lung issue was not reported. The relationship between ZOSTAVAX and the lung issue was not reported. Additional information has been requested.
my legs are like bubbling like in a hot tub; nerves have never stopped; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset Mar2021, outcome "unknown", described as "my legs are like bubbling like in a hot tub"; NEURALGIA (non-serious) with onset Mar2021, outcome "not recovered", described as "nerves have never stopped".  Additional information: Patient took the two covid vaccine almost 3 years ago, in march two days after the vaccine and I didn't know it was yours it was Pfizer and the day after I took it, I went to the doctor because my legs maybe I should have called you about that a long time ago but my legs are like bubbling like in a hot tub and like little pop all over the place I called it like 'popcorn'. The nerves have never stopped since that time they're like the feeling that it is, Because of that concern I am concerned about taking the Paxlovid   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
High blood sugar (250-350 range) going on 3 days now.  This also occurred after getting Covid but otherwise has been well controlled for years.  Will probably need to seek medical assistance if it continues more than a couple of more days or gets much higher.
About 18 hours after she got the shot, she started passing out.  This happened 9 times over the 24 hour period. She got a CT, MRI, 2 hour EEG and a 24 hour EEG. All of her test came back normal.
pt recv vax 23OCT97 & 4NOV97 pt devel a local rxn;
Patient had severe lung disease and I did consider him terminal but he had high dose flu vaccine and died soon after getting vaccine. Vaccine given 9/25/14 and patient died 10/2/2014. Presumed cause of death respiratory failure with underlying pulmonary fibrosis.
Lingering fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Lingering fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical information history was reported.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced FATIGUE (Lingering fatigue). At the time of the report, FATIGUE (Lingering fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Blood pressure measurement: high (High) High.         No concomitant medications were reported. No treatment medications were mentioned   Reporter did not allow further contact
Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 042j21a) for COVID-19 vaccination.     It was unknown whether patient was diagnosed or had tested positive for Covid -19  It was unknown whether patient had acute illness at the time of vaccination and upto one month prior. It was unknown whether patient had chronic or long standing health conditions.     On 11-May-2022 at 8:00 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 11-May-2022 at 8:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 11-May-2022, which had got expired on the 29-Apr-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Hcp reported they administered a vaccine that expired on the 29Apr2022 to less 5 patients. It was unknown on which date the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions Treatment details were not given.   This case was linked to MOD-2022-573908 (Patient Link).
Patient received half a dose instead of full first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received half a dose instead of full first dose) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (Patient received half a dose instead of full first dose). On 24-Dec-2021, ACCIDENTAL UNDERDOSE (Patient received half a dose instead of full first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.
Patient was given a 0.25 mL of Moderna Bivalent Booster dose on 9/15/2022. Patient documentation shows the lot number for bivalent.  The information was presented to staff on 9/27/22. The patient was called on 9/28/22. Patient made aware received a 0.25 mL of Moderna Bivalent Booster dose. Patient verbalized understanding. Patient denies having distress at the time of call. Patient denied having to go to the Emergency room or Primary Care provider. Informed the patient according to Moderna the recommendation was to re vaccinate with full dose in 8 weeks from 9/15/2022. Patient stated would like to be re vaccinated. Patient made aware will reach out to patient regarding receiving full vaccination. Patient Verbalized understanding.
On September 21, 2023, the patient received a dose of bivalent Pfizer vaccine. This vaccine was deauthorized on September 11, 2023, FDA authorized updated mRNA COVID-19 vaccines formulated to protect against COVID -19 due to currently circulating variants
Pt c/o fingers and toes were tingling and arms felt numb. Approx 1-2 hours after injection pt came back to Dr office walked into room alert. Neuro exam neg. Called pts home 4/31/06 pt doing fine.
Patient felt weak and light headed and had a syncope episode in the chair 5-10 minutes after injection was given
fell off chair at home, hit head, vomiting, Confused when arrived at ER, DX. Seizure normal labs, CT, neg. tox. screen urine
On April 12th I suddenly began feeling fatigue, light headed, weak in my knees, brain fog and inability to concentrate.  I went to the ER because I was fearful of passing out.  Nothing was found to be wrong with my vitals, and a check for heart attack was negative.  I received my second Pfizer vaccine on April 21, 2021 at 1:15PM at a pharmacy.  I experienced ear pain, head pressure, brain fog, fatigue and unsteadiness most everyday, with some days being worse than others.  I was in bed most of the day and avoided any stimuli including TV, or loud noises of any kind as my ears were also painful.    I went to the ER again on May 6th because of the feeling that I might pass out.  I had an MRI of my head done at that time, and nothing notable was detected, so I was sent home  I was diagnosed with Labyrinthitis by Neurologist Dr. on or about May 14th 2021 and started a course of Prednisone.  The Prednisone was helpful for the time I was taking it, but my symptoms returned after the first course.  I was ordered a second course with similar results.  I have more to say - but my session is about to time out.    I took my booster in November (Moderna).   I still have symptoms, although they are receding.
This is a case of breakthrough COVID-19 disease that resulted in death.   The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19.   This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021.   The death certificate details are as follows:  Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy
Upon administration of the vaccine I felt no tension or resistance, so out of concern that something was wrong I withdrew the needle and after a brief delay the vaccine sprayed out of the syringe and I put it in the sharps container.
4-5 hrs after vaccination pt started with (L) deltoid pain & shoulder, elbow, then pain to all joints & briefly lasted 24 - 30 hrs. Headache, anterior chest heaviness with some trouble breathing. Possible wheezing.
injection site for second dose was defiinitely more sore; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced pain in arm after vaccination. This is 1 of the 4 linked cases reported by the same reporter.
Initial unsolicited misuse report received from (LPN) Register Nurse on 24 January 2017. This case involves a 57 years old female patient who was inadvertently vaccinated intradermally with 0.1 milliliter dose of DIPHTHERIA AND TETANUS TOXOIDS (DT) (lot number, expiration date unknown) instead of TUBERCULIN PPD (lot number, expiration date and dose unknown) in the left forearm on an unknown date of December 2016. Patient's medical history as pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was reported as none and Illness at the time of vaccination were reported as unknown. On an unknown date, unspecified time following the vaccination patient had developed a lesion in left forearm which was not nodular and erythema. This was a case of Wrong drug administered, Drug administered at inappropriate site. The patient had emergency visit on an unknown date. Lab data and corrective treatment was not reported. The patient was recovered from the events on an unknown date. List of the documents held by sender: none.
Information has been received from a physician who reported that a mother chose to stop her daughter's GARDASIL due to "bad press". The article " teens believe GARDASIL make them sick" was in newspaper on 29-OCT-2009 concerning three girls, known as the "GARDASIL Girls" had experiences after receiving the vaccine. On an unspecified date the patient who was vaccinated with a dose of GARDASIL (lot # not reported). On an unspecified date she experienced charley horse, spasms and pain in muscles with fainting, nausea, irregular heartbeat and rash since she received GARDASIL. The patient's outcome was not reported. This is one of three reports form the same source. No additional information is available.
Information has been received from a physician concerning an 8 year old female, who on 15-NOV-2000 was vaccinated with a 0.5mL dose of varicella virus vaccine live (Oka/Merck). It was reported that the patient developed a full blown case of chickenpox. The family of three children received the vaccine and two of the older children developed a full blown case of chickenpox. Unspecified medical attention was sought. The patient's status at the time of the report was recovered. No product quality was involved. It was reported that the patient's brother WAES# 0704USA06527 experienced a similar adverse event following vaccination with varicella virus vaccine live. Additional information has been requested.
This spontaneous report was received from a researcher, and refers to an unspecified patient of unknown age and gender. Concurrent condition or medical history were not reported. On 16-MAR-2015, the patient received an improperly stored dose of ZOSTAVAX, subcutaneously, lot # K007548; Exp date 23-AUG-2015 (strength, dose #, dose and anatomical location were not provided). There was not concomitant medication reported. No adverse experiences were reported. There was not a product quality complaint involved. At the time of the report, the outcome of incorrect product storage was unknown. This is one of several reports received from the same reporter (1507USA005587 and 1507USA0055586). Additional information has been requested.
No immediate symptoms.  Started having a dry cough 3-4 days after receiving H1N1 nasal vaccine.  Cont to have minimal cough to 11-23-2009.  Required Tussinex cough medicine to control cough.